Literature DB >> 29573550

Relative quantification of beta-adrenergic receptor in peripheral blood cells using flow cytometry.

Didem Saygin1, Nicholas Wanner1, Jonathan A Rose2, Sathyamangla V Naga Prasad3, W H Wilson Tang3,4, Serpil Erzurum1,5, Kewal Asosingh1,6.   

Abstract

Beta-adrenergic receptors (β-ARs) play a critical role in many diseases. Quantification of β-AR density may have clinical implications in terms of assessing disease severity and identifying patients who could potentially benefit from beta-blocker therapy. Classical methods for β-AR quantification are based on labor-intensive and time-consuming radioligand binding assays. Here, we report optimization of a flow cytometry-based method utilizing a biotinylated β-AR ligand alprenolol as a probe and use of this method to quantify relative receptor expression in healthy controls (HC). Quantum™ MESF beads were used for quantification in absolute fluorescence units. The probe was chemically modified by adding a spacer moiety between biotin and alprenolol to stabilize receptor binding, thus preventing binding decay. Testing of three different standard cell fixation and permeabilization methods (formaldehyde fixation and saponin, Tween-20, or Triton-X 100 permeabilization) showed that the formaldehyde/Triton-X 100 method yielded the best results. β-AR expression was significantly higher in granulocytes compared to mononuclear cells. These data show that flow cytometric quantification of relative β-AR expression in circulating leukocytes is a suitable technology for large-scale clinical application.
© 2018 International Society for Advancement of Cytometry. © 2018 International Society for Advancement of Cytometry.

Entities:  

Keywords:  beta-adrenergic receptor peripheral blood cells; flow cytometry; quantification

Mesh:

Substances:

Year:  2018        PMID: 29573550      PMCID: PMC7263462          DOI: 10.1002/cyto.a.23358

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  31 in total

1.  Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis.

Authors:  J W Karaszewski; A T Reder; R Maselli; M Brown; B G Arnason
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

2.  Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration.

Authors:  S V Naga Prasad; L S Barak; A Rapacciuolo; M G Caron; H A Rockman
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

3.  Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.

Authors:  L T Williams; R Snyderman; R J Lefkowitz
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

Review 4.  Sympathetic nervous system-immune interactions in autoimmune lymphoproliferative diseases.

Authors:  Adriana del Rey; Hugo O Besedovsky
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

5.  Antibodies against beta1 and beta2 adrenergic receptors in myasthenia gravis.

Authors:  B Y Xu; R Pirskanen; A K Lefvert
Journal:  J Neuroimmunol       Date:  1998-11-02       Impact factor: 3.478

6.  Beta-adrenergic receptor number in human lymphocytes is inversely correlated with aerobic capacity.

Authors:  N Fujii; S Homma; F Yamazaki; R Sone; T Shibata; H Ikegami; K Murakami; H Miyazaki
Journal:  Am J Physiol       Date:  1998-06

7.  Formation of complexes between avidin and beta-adrenergic receptors using biotinyl-alprenolol derivatives.

Authors:  K E Meier; A E Ruoho
Journal:  Biochim Biophys Acta       Date:  1983-12-27

8.  Beta adrenergic receptors in lymphocytes and granulocytes from patients with cystic fibrosis.

Authors:  P B Davis; L Dieckman; T F Boat; R C Stern; C F Doershuk
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  Human lymphocyte beta-adrenergic receptors are unaltered with age.

Authors:  I B Abrass; P J Scarpace
Journal:  J Gerontol       Date:  1981-05

10.  Flow Cytometric Quantification of Peripheral Blood Cell β-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension.

Authors:  Jonathan A Rose; Nicholas Wanner; Hoi I Cheong; Kimberly Queisser; Patrick Barrett; Margaret Park; Corrine Hite; Sathyamangla V Naga Prasad; Serpil Erzurum; Kewal Asosingh
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

View more
  5 in total

1.  Antibody-functionalized aluminum oxide-coated particles targeting neutrophil receptors in a multifrequency microfluidic impedance cytometer.

Authors:  Brandon K Ashley; Jianye Sui; Mehdi Javanmard; Umer Hassan
Journal:  Lab Chip       Date:  2022-08-09       Impact factor: 7.517

2.  Repeated social defeat promotes persistent inflammatory changes in splenic myeloid cells; decreased expression of β-arrestin-2 (ARRB2) and increased expression of interleukin-6 (IL-6).

Authors:  Dhaksshaginy Rajalingam; Ingeborg Nymoen; Daniel Pitz Jacobsen; Mina Baarnes Eriksen; Erik Dissen; Morten Birkeland Nielsen; Ståle Valvatne Einarsen; Johannes Gjerstad
Journal:  BMC Neurosci       Date:  2020-05-29       Impact factor: 3.288

3.  Multivalent interactions between molecular components involved in fast endophilin mediated endocytosis drive protein phase separation.

Authors:  Samsuzzoha Mondal; Karthik Narayan; Samuel Botterbusch; Imania Powers; Jason Zheng; Honey Priya James; Rui Jin; Tobias Baumgart
Journal:  Nat Commun       Date:  2022-08-26       Impact factor: 17.694

4.  β-blockers Reverse Agonist-Induced β2-AR Downregulation Regardless of Their Signaling Profile.

Authors:  Sonia Maccari; Vanessa Vezzi; Federica Barbagallo; Tonino Stati; Barbara Ascione; Maria Cristina Grò; Liviana Catalano; Giuseppe Marano; Paola Matarrese; Caterina Ambrosio; Paola Molinari
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

Review 5.  Neurohormonal modulation in pulmonary arterial hypertension.

Authors:  Eva L Peters; Harm Jan Bogaard; Anton Vonk Noordegraaf; Frances S de Man
Journal:  Eur Respir J       Date:  2021-10-28       Impact factor: 16.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.